APOE and Alzheimer disease: Consequently, the number of oligodendrocytes is lower in APOE4 brains across the AD continuum regardless of their Braak stage, amyloid deposition, and neuronal loss, suggesting that disruption of myelination in APOE4 carriers may represent a specific pathology in the aging brain [13].